Introduction: Liaoning Future Biotechnology Co., Ltd. is a joint-stock company controlled by Liaoning Institute of Biomedical Engineering. It is a high-tech biotechnology enterprise dedicated to human health industry, mainly engaged in research and development, production and sales of biological products (health food, food and biopharmaceuticals). ? Future? Biotech? Inc. is a wholly-owned subsidiary of the company established in the United States. ? At the beginning of 2111, it settled in China Yaodu (a national biomedical science and technology industrial base) in Benxi, Liaoning Province, with a registered capital of 84.45 million yuan, covering an area of 1.71 mu and a total investment of 211 million yuan. It is one of the largest antioxidant enzyme production bases in China at present. ? The company has excellent biotechnology talents, advanced technical equipment and strong economic strength. The method of extracting compound antioxidant enzyme from corn germ won the national patent in 2113, and the closed biological extraction technology of quantitative production was the first in the world, and it applied for the national patent in 2114. The compound antioxidant enzyme "Yuannuo Capsule" produced by this patented technology was certified by the domestic authority China Food and Drug Administration "Little Blue Hat" and the international authority FDA. The effects of certification are: delaying aging, improving sleep quality and enhancing health immunity. ? ? At the beginning of 2113, the products were mass-produced, and they were sought after by the health care peers when they went on the market. At present, the compound marketing model is based on direct selling, supplemented by agency, wholesale, retail and Tmall.

legal representative: Zhuang jiurong

date of establishment: 2111-13-31

registered capital: 84.45 million RMB

industrial and commercial registration number: 211111114946397

enterprise type: limited liability company (natural person investment or holding)

company address: Benxi Economy.